These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
6. T cells bearing Vbeta8 are preferentially infected with exogenous mouse mammary tumor virus. Upragarin N; Nishimura H; Wajjwalku W; Ando Y; Nagafuchi S; Watanabe T; Yoshikai Y J Immunol; 1997 Sep; 159(5):2189-95. PubMed ID: 9278306 [TBL] [Abstract][Full Text] [Related]
7. Deletion of CD4+ T cells and thymocytes by apoptosis in mouse mammary tumor virus (C4)-infected V beta 2 transgenic mice. Wang H; Gill RF; Lichlyter D; Iglesias A; Bluethmann H; Wei WZ Eur J Immunol; 1994 Dec; 24(12):2950-6. PubMed ID: 7805721 [TBL] [Abstract][Full Text] [Related]
8. A V beta 4-specific superantigen encoded by a new exogenous mouse mammary tumor virus. Maillard I; Erny K; Acha-Orbea H; Diggelmann H Eur J Immunol; 1996 May; 26(5):1000-6. PubMed ID: 8647159 [TBL] [Abstract][Full Text] [Related]
9. The role of CD28 costimulation in immune-mediated responses against mouse mammary tumor viruses. Palmer LD; Saha B; Hodes RJ; Abe R J Immunol; 1996 Mar; 156(6):2112-8. PubMed ID: 8690899 [TBL] [Abstract][Full Text] [Related]
10. Activation of natural killer cells by mouse mammary tumor virus C4 in BALB/c and T-cell receptor V beta 2-transgenic mice. Gill R; Wang H; Bluethmann H; Iglesias A; Wei WZ Cancer Res; 1994 Mar; 54(6):1529-35. PubMed ID: 8137259 [TBL] [Abstract][Full Text] [Related]
11. Maternal transfer of infectious mouse mammary tumor retroviruses does not depend on clonal deletion of superantigen-reactive V beta 14+ T cells. Penninger JM; Wallace VA; Timms E; Mak TW Eur J Immunol; 1994 May; 24(5):1102-8. PubMed ID: 8181521 [TBL] [Abstract][Full Text] [Related]
12. A kinetic study on the deletion of thymic, peripheral, and gut-associated V beta 6+ T cells in an Mls-1b BALB/c colony infected with an exogenous mouse mammary tumor virus. Tucek CL; Desaymard C; Papiernik M J Immunol; 1993 Jul; 151(2):759-66. PubMed ID: 8101538 [TBL] [Abstract][Full Text] [Related]
13. Transfer of endogenous retroviral superantigen from donor to recipient B cells following priming to induce peripheral T cell tolerance. Modlin CS; Todd GT; Cohen TD; Fairchild RL Cell Immunol; 1995 Sep; 164(2):217-26. PubMed ID: 7656330 [TBL] [Abstract][Full Text] [Related]
14. T cell receptor V beta repertoire in mice lacking endogenous mouse mammary tumor provirus. Braun MY; Jouvin-Marche E; Marche PN; MacDonald HR; Acha-Orbea H Eur J Immunol; 1995 Mar; 25(3):857-62. PubMed ID: 7705418 [TBL] [Abstract][Full Text] [Related]
15. Identification of key amino acids of the mouse mammary tumor virus superantigen involved in the specific interaction with T-cell receptor V(beta) domains. Baribaud F; Wirth S; Maillard I; Valsesia S; Acha-Orbea H; Diggelmann H J Virol; 2001 Aug; 75(16):7453-61. PubMed ID: 11462017 [TBL] [Abstract][Full Text] [Related]
16. B and T cells are required for mouse mammary tumor virus spread within the mammary gland. Golovkina TV; Dudley JP; Ross SR J Immunol; 1998 Sep; 161(5):2375-82. PubMed ID: 9725233 [TBL] [Abstract][Full Text] [Related]
17. T cell deletion induced by chronic infection with mouse mammary tumor virus spares a CD25-positive, IL-10-producing T cell population with infectious capacity. Papiernik M; do Carmo Leite-de-MoraesM ; Pontoux C; Joret AM; Rocha B; Penit C; Dy M J Immunol; 1997 May; 158(10):4642-53. PubMed ID: 9144476 [TBL] [Abstract][Full Text] [Related]
18. Thymic repertoire selection by superantigens: presentation by human and mouse MHC molecules. Simpson E; Takacs K; Altmann DM Thymus; 1994; 23(1):1-13. PubMed ID: 7863543 [TBL] [Abstract][Full Text] [Related]
20. Characterization of the Mlsf system. II. Identification of mouse mammary tumor virus proviruses involved in the clonal deletion of self-Mlsf-reactive T cells. Foo-Phillips M; Kozak CA; Principato MA; Abe R J Immunol; 1992 Dec; 149(11):3440-7. PubMed ID: 1331236 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]